Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Wed, Apr 1, 2026
10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm
Cath Jayasuriya
Click To Register
View all
UPCOMING SESSIONS
in
ET
Wed, Apr 1, 2026 · 10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm
Cath Jayasuriya
Click To Register
View all sessions
All Upcoming Sessions
3
APR
1
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm
Wed, Apr 1, 2026 · 10:00 – 11:00 PM UTC
Cath Jayasuriya
Register
APR
2
You Are Not Behind. You Are in Different Territory.
Thu, Apr 2, 2026 · 10:00 – 11:00 PM UTC
Francesco Clark
Register
APR
8
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
Heather Landau
Register
Dexamethasone
Home
Dexamethasone
Jun 03, 2018
Subcutaneous Daratumumab (DARA SC) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (Cybord) in Patients (Pts) With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Safety Run-in Results of Andromeda
Background: Systemic AL amyloidosis is characterized by disposition of insoluble amyloid fibrils into tissues and organs via clonal expansion of CD38+ plasma cells…
Read more
Subscribe to
